TIALD and hepatocellular carcinoma: Taking together, our findings demonstrate that, on the one hand, METTL16 and its induced m6A methylation are involved in the downregulation of TIALD; and on the other hand, TIALD inhibits the degradation of AURKA, which in turn promotes HCC metastasis.